Stephen Donnelly (Wicklow, Fianna Fail) | Oireachtas source

Let us say, in the case of a global pharmaceutical company, that a decision is made at a governmental or EU level to target lung cancer. While I have not seen the figures for a while, ten years ago the research and development cost for a typical blockbuster drug was approximately $5 billion, although I imagine it has risen considerably.

Is the proposal that EU funds would be created whereby Pfizer, GSK or whoever it is, would be handed $5 billion or $20 billion and asked to develop drugs for specified diseases?